Wilbanks Smith & Thomas Asset Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,800	Closed	-$278K	–	525
2022 Q1	$278K	Hold	15,800	–	–	0.01%	409
2021 Q4	$338K	Hold	15,800	–	–	0.01%	390
2021 Q3	$292K	Buy	15,800 +2,800	+22%	+$56.4K	0.01%	393
2021 Q2	$278K	Buy	+13,000	New	+$264K	0.01%	413

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's OCDX Position: Q2 2022 in Review

Wilbanks Smith & Thomas Asset Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 15,800 shares — an estimated $278K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $338K in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Wilbanks Smith & Thomas Asset Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Wilbanks Smith & Thomas Asset Management sold 15,800 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $278K.
Wilbanks Smith & Thomas Asset Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 4 quarters.
Wilbanks Smith & Thomas Asset Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $338K in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q2 2022, filed 3 Aug 2022.